Pharmatek offers broad finished product services for the development of small molecule drug candidates. Since our founding in 1999, Pharmatek’s scientists have served over 230 clients globally and supported on more than 200 small molecule candidates with a range of physiochemical characteristics. Our proven know-how and deep experience with small molecule drug development can help improve the bioavailability of your compound, overcome challenging timelines, improve patient compliance, and efficiently move your compound to the next phase of development.
Our experience includes first-in-man strategies, solutions for poorly soluble compounds, controlled release and pediatric formulations & separate facilities for the handling of cytotoxic & potent compounds. Pharmatek’s drug delivery technologies include:
• Solid Dispersions
• Particle Size Reduction
• Lipid Delivery
• Suspensions & Emulsions
The Pharmatek Difference
Pharmatek’s small molecule development expertise is grounded in our understanding of chemistry, preformulation and pharmaceutical development. We pride ourselves on our data-driven approach to development and our client-centric service model that ensures customized project plans, fast project initiation, solid science and on-time delivery. From candidate selection and first-in-man to scale up and tech transfer, our CMC experts will deliver the results to help you advance your candidate to the next phase.
Contact us to discuss your project and learn more about our development expertise for small molecule candidates.